Oxcarbazepine-D4 is a deuterated form of oxcarbazepine, which is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder. The "D4" designation indicates that this compound contains four deuterium atoms, which are isotopes of hydrogen, replacing the regular hydrogen atoms in the molecular structure. This modification is often utilized in research and analytical applications, particularly in pharmacokinetics and metabolic studies, as it allows for the differentiation of the compound from its non-deuterated counterpart in various assays. Oxcarbazepine itself is known for its ability to stabilize mood and reduce seizure frequency by modulating sodium channels in the brain. The deuterated version may exhibit slightly altered pharmacokinetic properties due to the presence of heavier isotopes, which can affect the compound's metabolism and elimination. Overall, Oxcarbazepine-D4 serves as a valuable tool in scientific research, providing insights into the behavior and effects of oxcarbazepine in biological systems.

Oxcarbazepine-d
4
is intended for use as an internal standard for the quantification of oxcarbazepine by GC- or LC-MS. Oxcarbazepine is a prodrug form of the antiepileptic compound 10,11-dihydro-10-hydroxy carbamazepine . It inhibits high-frequency repetitive firing of rat spinal cord neurons when used at a concentration of 1 μM. Oxcarbazepine protects against electroshock-induced tonic hindlimb extension (ED
50
s = 10-20 mg/kg), as well as seizures induced by pentylenetetrazole (PTZ; ) or picrotoxin in rodents (ED
50
s = 23-30 and 150-250 mg/kg, respectively). Formulations containing oxcarbazepine have been used in the treatment of epileptic seizures.

OXCARBAZEPINE-D4

1134188-71-8: Oxcarbazepine-D4 is a deuterated form of oxcarbazepine, which is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder. The "D4" designation indicates that this compound contains four deuterium atoms, which are isotopes of hydrogen, replacing the regular hydrogen atoms in the molecular structure. This modification is often utilized in research and analytical applications, particularly in pharmacokinetics and metabolic studies, as it allows for the differentiation of the compound from its non-deuterated counterpart in various assays. Oxcarbazepine itself is known for its ability to stabilize mood and reduce seizure frequency by modulating sodium channels in the brain. The deuterated version may exhibit slightly altered pharmacokinetic properties due to the presence of heavier isotopes, which can affect the compound's metabolism and elimination. Overall, Oxcarbazepine-D4 serves as a valuable tool in scientific research, providing insights into the behavior and effects of oxcarbazepine in biological systems.

CAS 1134188-71-8

OXCARBAZEPINE-D4

Oxcarbazepine-6,7,8,9-d4 (Aniline-6,7,8,9-d4)

Ref: 4Z-O-063